News and Trends 13 Sep 2022
Arpeggio Biosciences raises $17M in Series A funding to support drug pipeline
Arpeggio Biosciences has raised $17 million in series A funding in a round led by Builders VC. Support for the U.S.-based preclinical therapeutics company making technology targeting transcriptional dysregulation in…
